US And Canada

Aptiv and CAC Holdings joined corporate venturing units Trend Forward Capital and Motley Fool Ventures in a $26m round that almost doubled the MIT spinout's funding.

Based on research at University of Notre Dame, Happe Spine is working on implants for interbody spinal fusion.

Congruent Ventures has led a $2.5m funding round for Energetic Insurance, which hopes to enable SMEs to tap into the solar energy market.

Indiana University Philanthropic Venture Fund has made its tenth investment, putting $200,000 into Confluence Pharmaceuticals.

Stanford-StartX Fund has supported a $4m round for Imprimed, which is working on precision cancer treatments for dogs.

The House Fund has made its second investment in additive manufacturing software developer Dyndrite as part of a round that raised more than $10m.

Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.

As MedWhat scores an initial win in its courtroom battle with Stanford, Paige.ai finds itself in the middle of allegations that its licensing deal with Sloan Kettering was improper.

Ambys Medicines has raised $60m in a series A round backed by Takeda and signed a strategic partnership agreement with the corporate worth $80m.

VW will invest $100m in QuantumScape and form a joint venture with the Stanford spinout to develop batteries for long-range electric vehicles.